glp 1 period changes GLP-1 receptor agonists and risk of suicide or suicide attempts – A nationwide cohort and self-controlled case series study GLP-1 receptor agonists | How

On 19 March 2026, the FDA approved a higher-dose formulation of semaglutide, Wegovy HD, at 7.2 mg for once-weekly subcutaneous administration

These programs gave us the flexibility to take risks, support students and sustain a long-term project that would have been very difficult to do otherwise. Those relatively modest awards helped fund years of experimental work, particularly in an area where costs can be high and timelines long

Listen to Your Gut (Literally!) While Taking GLP-1: Dont ignore the urge to go, as this can worsen constipation, particularly when the digestive system is already slowed down by GLP-1 drugs

We can usually make it happen